Dexcom G7 15 Day receives FDA clearance
Dexcom G7 15 Day is now cleared in the U.S. for people age 18 years and above with diabetes.
Diabetes
Global Data forecasts Type 1 diabetes market to reach $9.9 billion by 2033
"According to primary research conducted by GlobalData, high volumes of prescribing physicians and patients have demonstrated positive attitudes towards the use of ultra-rapid insulin analogs, which is expected to drive T1D market growth.”
National Diabetes Awareness Month: Shining a spotlight on Hispanic Americans
As part of National Diabetes Awareness Month, Cardinal Health is focusing on the Hispanic American population, which is one of the top high-risk populations for diabetes.
eddii launches eddii-Care for adults
Following introduction of pediatric care in 37 states, innovative health tech company focused on diabetes management expands virtual care to adults, starting in the states of New Jersey, Washington, and Maryland
ADA teaming with pharmaceutical suppliers to support the needs of people with diabetes
Association working with Abbott and Gentech.
Study: Majority of GLP-1 users discontinue drug early
The survey of people between the ages of 21 and 75 found that more than three-quarters (78%) discussed lifestyle changes with their prescriber before receiving or when receiving a GLP-1 medication.